149 related articles for article (PubMed ID: 33904617)
1. Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma.
Xu H; Lu L; Lu T; Xu Y; Zong J; Huang C; Lin F; Zheng Y; Lin C; Lin S; Qiu S; Pan J; Lin S; Guo Q
Head Neck; 2021 Sep; 43(9):2602-2610. PubMed ID: 33904617
[TBL] [Abstract][Full Text] [Related]
2. Effects of locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world study.
Zeng F; Lu T; Xie F; Chen L; Zhang L; Su Y; Yu Z; Xiao Y; Ao F; Li G; Chen Z; Gong X; Li J
Transl Oncol; 2021 Nov; 14(11):101187. PubMed ID: 34365221
[TBL] [Abstract][Full Text] [Related]
3. Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
Sun XS; Liu LT; Liu SL; Guo SS; Wen YF; Xie HJ; Tang QN; Liang YJ; Li XY; Yan JJ; Ma J; Chen QY; Tang LQ; Mai HQ
BMC Cancer; 2019 Jan; 19(1):92. PubMed ID: 30665378
[TBL] [Abstract][Full Text] [Related]
4. Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis.
Lin C; Lin S; Zhu L; Lin S; Pan J; Xu Y
BMC Cancer; 2022 Jan; 22(1):35. PubMed ID: 34983459
[TBL] [Abstract][Full Text] [Related]
5. Locoregional radiotherapy improves survival outcomes in de novo metastatic nasopharyngeal carcinoma treated with chemoimmunotherapy.
Hu YJ; Lu TZ; Zhang H; Fang M; Chen BJ; Guo QJ; Lin SJ; Feng P; Wang Y; Jiang TC; Gong XC; Pan JJ; Li JG; Xia YF
ESMO Open; 2023 Oct; 8(5):101629. PubMed ID: 37660406
[TBL] [Abstract][Full Text] [Related]
6. Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
Yang JH; Sun XS; Xiao BB; Liu LT; Guo SS; Liang JD; Jia GD; Tang LQ; Chen QY; Mai HQ
BMC Cancer; 2021 May; 21(1):534. PubMed ID: 33975558
[TBL] [Abstract][Full Text] [Related]
7. Effective of metastasis-directed therapy for de novo metastatic nasopharyngeal carcinoma: A propensity score matched analysis.
Liu GY; Li Z; Chen XX; Xia WX; Yao HR; Xiang YQ
Head Neck; 2023 Oct; 45(10):2571-2579. PubMed ID: 37554098
[TBL] [Abstract][Full Text] [Related]
8. Prognostic model for risk stratification of de novo metastatic nasopharyngeal carcinoma patients treated with chemotherapy followed by locoregional radiotherapy.
Li WZ; Hua X; Xie DH; Liang H; Liu GY; Xia WX; Xiang YQ
ESMO Open; 2021 Feb; 6(1):100004. PubMed ID: 33399071
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the Treatment Pattern for
Sun XS; Liang YJ; Chen QY; Guo SS; Liu LT; Sun R; Luo DH; Tang LQ; Mai HQ
Front Oncol; 2020; 10():543646. PubMed ID: 33194602
[TBL] [Abstract][Full Text] [Related]
10. M1 stage subdivisions based on
Qiu HZ; Zhang X; Liu SL; Sun XS; Mo YW; Lin HX; Lu ZJ; Guo J; Tang LQ; Mai HQ; Liu LT; Guo L
Ther Adv Med Oncol; 2022; 14():17588359221118785. PubMed ID: 35983026
[TBL] [Abstract][Full Text] [Related]
11. Proposed prognostic subgroups and facilitated clinical decision-making for additional locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a retrospective study based on recursive partitioning analysis.
Yao Y; Sun X; Huang H; Wang Z; Fang X; Chen M; Chen Z; Weng H; Guo C; Hong H; Huang H; Lin T
Radiat Oncol; 2023 Jan; 18(1):15. PubMed ID: 36681832
[TBL] [Abstract][Full Text] [Related]
12. Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World Study.
Li WZ; Lv SH; Liu GY; Liang H; Guo X; Lv X; Liu KY; Qiang MY; Chen X; Gu SZ; Xie CQ; Xia WX; Xiang YQ
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):120-130. PubMed ID: 32853711
[TBL] [Abstract][Full Text] [Related]
13. Risk-adapted locoregional radiotherapy strategies based on a prognostic nomogram for de novo metastatic nasopharyngeal carcinoma patients treated with chemoimmunotherapy.
Chen Y; Chen C; Peng H; Lin S; Pan J; Zheng H; Zong J; Lin C
Sci Rep; 2024 Feb; 14(1):3950. PubMed ID: 38366057
[TBL] [Abstract][Full Text] [Related]
14. First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for
Yang ZC; Liu T; Chen YZ; Guo CY; Liu LT; Liu SL; Chen QY; Mai HQ; Guo SS
Cancer Control; 2022; 29():10732748221124868. PubMed ID: 36047451
[TBL] [Abstract][Full Text] [Related]
15. Systemic chemotherapy followed by locoregional definitive intensity-modulated radiation therapy yields prolonged survival in nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis.
Hu SX; He XH; Dong M; Jia B; Zhou SY; Yang JL; Yang S; Zhang CG; Liu P; Qin Y; Gui L
Med Oncol; 2015 Sep; 32(9):224. PubMed ID: 26219572
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy.
Yan W; Sun C; Ou X; Hu C
Cancer Imaging; 2023 Feb; 23(1):21. PubMed ID: 36829263
[TBL] [Abstract][Full Text] [Related]
17. Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion.
Liao S; Xie Y; Feng Y; Zhou Y; Pan Y; Fan J; Mi J; Qin X; Yao D; Jiang W
J Cancer Res Clin Oncol; 2020 Feb; 146(2):429-439. PubMed ID: 31677113
[TBL] [Abstract][Full Text] [Related]
18. Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma.
Liu ZQ; Zhao YN; Wu YS; Zhang BY; Chen EN; Peng QH; Xiao SM; OuYang D; Xie FY; OuYang PY
Oral Oncol; 2023 Dec; 147():106583. PubMed ID: 37837738
[TBL] [Abstract][Full Text] [Related]
19. Addition of chemoradiotherapy to palliative chemotherapy in de novo metastatic nasopharyngeal carcinoma: a real-world study.
Zheng SH; Wang YT; Liu SR; Huang ZL; Wang GN; Lin JT; Ding SR; Chen C; Xia YF
Cancer Cell Int; 2022 Jan; 22(1):36. PubMed ID: 35073926
[TBL] [Abstract][Full Text] [Related]
20. The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study.
Sun XS; Liu SL; Liang YJ; Chen QY; Li XY; Tang LQ; Mai HQ
Cancer Commun (Lond); 2020 Jan; 40(1):32-42. PubMed ID: 32112522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
